Conference/Symposium 2026 Baxter Foundation Distinguished Lecture/ReMS - Daniel Drucker, MD, Senior Scientist, Lunenfeld-Tanenbaum Research Institute "GLP-1 medicines, how and where do they work?" Sponsored by Clark Center, Auditorium 318 Campus Drive, Stanford, CA 94305 View map This event is open to: Students Students - Undergraduates Postdocs Faculty Staff I'm Interested Share: Share 2026 Baxter Foundation Distinguished Lecture/ReMS - Daniel Drucker, MD, Senior Scientist, Lunenfeld-Tanenbaum Research Institute "GLP-1 medicines, how and where do they work?" on Facebook Share 2026 Baxter Foundation Distinguished Lecture/ReMS - Daniel Drucker, MD, Senior Scientist, Lunenfeld-Tanenbaum Research Institute "GLP-1 medicines, how and where do they work?" on X Share 2026 Baxter Foundation Distinguished Lecture/ReMS - Daniel Drucker, MD, Senior Scientist, Lunenfeld-Tanenbaum Research Institute "GLP-1 medicines, how and where do they work?" on LinkedIn

In the Seahorse analysis, the HEB cell line exhibited significant changes in energy metabolism after drug treatment compared to untreated cells, with the combined use of metformin and simvastatin showing no advantage over individual drug treatments
Shaikh, R
Alternatively, the suppression of the lipid flippase solute carrier family 47 member 1 (SLC47A1) enhances ferroptosis by favoring the ACSL4sterol O-acyltransferase 1 (SOAT1) pathway over the ACSL4LPCAT3 pathway, leading to the production of PUFA cholesterol esters in pancreatic cancer cells [102]
Without maintenance and healthy lifestyle support, results may gradually diminish over several months